SwePub
Sök i LIBRIS databas

  Utökad sökning

(WFRF:(Jonas JB)) srt2:(2007-2009)
 

Sökning: (WFRF:(Jonas JB)) srt2:(2007-2009) > (2008) > Urodynamic evaluati...

Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence.

Groenendijk, PM (författare)
Lycklama à Nyeholt, AA (författare)
Heesakkers, JP (författare)
visa fler...
van Kerrebroeck, PE (författare)
Hassouna, MM (författare)
Gajewski, JB (författare)
Cappellano, F (författare)
Siegel, SW (författare)
Fall, Magnus, 1941 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences
Dijkema, HE (författare)
Jonas, U (författare)
Van den Hombergh, U (författare)
Sacral Nerve Stimulation Study Group, (författare)
visa färre...
 (creator_code:org_t)
2008
2008
Engelska.
Ingår i: BJU International. - 1464-4096. ; 101:3, s. 325-329
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • To evaluate the urodynamic data before and 6 months after implantation of sacral neuromodulation (SNM, an established treatment for voiding dysfunction, including refractory urge urinary incontinence, UI) and to assess the correlation between the urodynamic data and clinical efficacy in patients with UI. PATIENTS AND METHODS In all, 111 patients with a >50% reduction in UI symptoms during a percutaneous nerve evaluation test qualified for surgical implantation of SNM. Patients were categorized in two subgroups, i.e. those with UI with or without confirmed detrusor overactivity (DO) at baseline. At the 6-month follow-up all patients had a second urodynamic investigation, with the stimulator switched on. RESULTS At baseline, there was urodynamically confirmed DO in 67 patients, while 44 showed no DO. A review of filling cystometry variables showed a statistically significant improvement in bladder volumes at first sensation of filling (FSF) and at maximum fill volume (MFV) before voiding for both UI subgroups, compared with baseline. In 51% of the patients with UI and DO at baseline, the DO resolved during the follow-up. However, those patients were no more clinically successful than those who still had DO (P = 0.73). At the 6-month follow-up, 55 of 84 implanted patients showed clinical benefit, having a ≥50% improvement in primary voiding diary variables. Patients with UI but no DO had a higher rate of clinical success (73%) than patients with UI and DO (61%), but the difference was not statistically significant. CONCLUSION These urodynamic results show a statistically significant improvement in FSF and MFV in patients with UI with or with no DO after SNM. Although there was a urodynamic and clinical improvement in both groups, patients with UI but no DO are at least as successful as patients with UI and DO. Therefore in patients with UI, DO should not be a prerequisite selection criterion for using SNM.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Urology and Nephrology (hsv//eng)

Nyckelord

Detrusor overactivity
Sacral neuromodulation
Urge urinary incontinence
Urodynamics

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy